|
KMID : 0614720190620050240
|
|
Journal of Korean Medical Association
2019 Volume.62 No. 5 p.240 ~ p.242
|
|
|
Regulated sandbox and disease-related genetic tests as a direct-to-consumer test
|
|
Kim Jong-Won
|
|
|
Abstract
|
|
|
|
Recently, the Korean government introduced a regulatory sandbox that includes direct-to-consumer (DTC) genetic tests. Several genetic testing companies received approval for predictive DTC genetic tests for conditions ranging from cancer to chronic diseases. However, it is not evident how DTC tests should be carried out and interpreted. It does not seem to estimate the accuracy of the predictive genetic testing from a two-year exemption trial. However, clinical laboratories can no longer explore innovative approaches to genetic testing because of the restrictive regulatory and legal environment. Genetic testing companies can provide DTC services without restrictions on facilities, equipment, and personnel although those testing services were not fully supported scientifically. Present situation in Korea on DTC genetic test should be reformed.
|
|
|
KEYWORD
|
|
|
Genetic test, Direct-to-consumer test, Regulated sandbox
|
|
|
FullTexts / Linksout information
|
|
 
|
|
|
Listed journal information
|
|
 
|